Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kontafarma China Holdings Ltd ( (HK:1312) ) has shared an update.
Kontafarma China Holdings Ltd announced the appointment of three new independent non-executive directors: Dr. Tang Lai Wah, Dr. Ho Ho Ming, and Mr. Yao Xiaomin. Each appointee has confirmed their independence and lack of financial interest in the company, ensuring compliance with relevant listing rules. This move is part of the company’s efforts to strengthen its board’s independence and governance.
More about Kontafarma China Holdings Ltd
Average Trading Volume: 1,001,200
Technical Sentiment Signal: Sell
Current Market Cap: HK$161.8M
For a thorough assessment of 1312 stock, go to TipRanks’ Stock Analysis page.